Cerebrospinal Fluid and Tuberculous Meningitis
- PMID: 36987607
- PMCID: PMC11487151
- DOI: 10.1093/cid/ciad186
Cerebrospinal Fluid and Tuberculous Meningitis
Conflict of interest statement
Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment in
-
Reply to Upton et al.Clin Infect Dis. 2023 Jul 5;77(1):158-159. doi: 10.1093/cid/ciad188. Clin Infect Dis. 2023. PMID: 36978221 Free PMC article. No abstract available.
Comment on
-
Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.Clin Infect Dis. 2022 Sep 10;75(4):682-689. doi: 10.1093/cid/ciab992. Clin Infect Dis. 2022. PMID: 34849645 Free PMC article.
References
-
- Akkerman OW, Odish OFF, Bolhuis MS, et al. Pharmacokinetics of bedaquiline in cerebrospinal fluid and serum in multidrug-resistant tuberculous meningitis. Clin Infect Dis 2015; 62:523–4. - PubMed
-
- Verhaeghe T, Diels L, Dillen L. Quantitation of bedaquiline: points of attention. Clin Infect Dis 2016; 63:145–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
